Key result
In patients with acute myocardial infarction complicated by cardiogenic shock undergoing primary PCI, a C-reactive protein level >1 mg/dl was significantly associated with an increased risk of major adverse cardiac events at 1 year (OR 6.27).
Population
147 patients with acute myocardial infarction complicated by cardiogenic shock undergoing primary…
Design
Cohort
Follow-up
1 year
Authors
Loading...
Elevated CRP may identify higher-risk AMI shock patients post-PCI; leaves open whether measurement should guide management.
Cohort (n=147)
No
Odds Ratio: 6.27 (95% CI 2.04–22.1)
p-value: p=0.002
In patients with AMI complicated by cardiogenic shock, achieving TIMI 3 flow during primary PCI reduces in-hospital mortality, while elevated CRP and low TIMI flow predict long-term MACE.
Lim et al. (2005) conducted a cohort in Acute myocardial infarction complicated by cardiogenic shock (n=147). C-reactive protein (CRP) >1 mg/dl vs. CRP ≤1 mg/dl was evaluated on Major adverse cardiac events (MACE) at 1 year (OR 6.27, 95% CI 2.04-22.10, p=0.002). In patients with acute myocardial infarction complicated by cardiogenic shock undergoing primary PCI, a C-reactive protein level >1 mg/dl was significantly associated with an increased risk of major adverse cardiac events at 1 year (OR 6.27).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: